Methodological improvements for measuring eicosanoids and cytokines in exhaled breath condensate

E. Tufvesson, L. Bjermer (Lund, Sweden)

Source: Annual Congress 2005 - Methodological considerations in noninvasive assessment of airway inflammation
Session: Methodological considerations in noninvasive assessment of airway inflammation
Session type: Thematic Poster Session
Number: 2402
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Tufvesson, L. Bjermer (Lund, Sweden). Methodological improvements for measuring eicosanoids and cytokines in exhaled breath condensate. Eur Respir J 2005; 26: Suppl. 49, 2402

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Validation of eicosanoid measurements in exhaled breath condensate
Source: Eur Respir J 2002; 20: Suppl. 38, 422s
Year: 2002

Technical problems with measurements of biomarkers - exhaled breath condensate
Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases
Year: 2017

Exhaled breath condensate: 8-isoprostane and eicosanoids
Source: Eur Respir Monogr 2010; 49: 196-206
Year: 2010


Monitoring of 24-hours variation of leukotrienes in exhaled breath condensate
Source: Annual Congress 2007 - Acute and chronic effects of air pollution
Year: 2007


Exercise-induced changes in concentrations of cysteinyl-leukotrienes in exhaled breath condensate
Source: Eur Respir J 2004; 24: Suppl. 48, 680s
Year: 2004

Breath condenser coatings affect measurement of biomarkers in exhaled breath condensate
Source: Eur Respir J 2006; 28: 1036-1041
Year: 2006



Cytokines in exhaled breath condensate of patients with asthma
Source: Annual Congress 2008 - Inflammatory biomarkers
Year: 2008

Exhaled breath condensate eicosanoids as markers of asthma severity
Source: Annual Congress 2008 - Understanding the mechanisms and the impact of severe asthma
Year: 2008


Inflammatory mediators in exhaled breath condensate, induced sputum and saliva
Source: Eur Respir J 2004; 24: Suppl. 48, 678s
Year: 2004

Correlation of LTB4 with α-amylase in exhaled breath condensate
Source: Eur Respir J 2005; 26: Suppl. 49, 372s
Year: 2005

Reproducibility of cysteinyl-leukotriene measurements in exhaled breath condensate in children
Source: Eur Respir J 2001; 18: Suppl. 33, 39s
Year: 2001

Profile of prostanoids in exhaled breath condensate in childhood asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 400s
Year: 2003

Monitoring airway inflammation after allergen challenge by measuring 8-isoprostane in exhaled breath condensate
Source: Annual Congress 2010 - Biomarkers and diagnosis of allergic inflammatory diseases
Year: 2010

Inflammatory cytokines in exhaled breath condensate (EBC) of exacerbated COPD patients
Source: Annual Congress 2008 - Inflammatory biomarkers
Year: 2008


Increased 8-isoprostane in the exhaled breath condensate of down patients
Source: Eur Respir J 2004; 24: Suppl. 48, 556s
Year: 2004

Endogenous and exogenous metabolites in exhaled breath condensate in asthma
Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases
Year: 2012

Reproducibility of exhaled breath condensate markers
Source: Eur Respir J 2008; 32:
Year: 2008